Low-dose Ranibizumab Effective for Retinopathy of Prematurity Low-dose Ranibizumab Effective for Retinopathy of Prematurity

Low doses of anti-VEGF therapy with ranibizumab are effective in infants with retinopathy of prematurity (ROP), according to results from the CARE-ROP study.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news